Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025)
Azitra (AZTR) posted Other Non-Current Liabilities of $51.0 for Q3 2025, down 72.28% on a QoQ basis from $184.0 in Q2 2025, and down 88.84% year-over-year from $457.0 in Q3 2024.
Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025) Analysis & Trends
Azitra's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $51.0 for Q3 2025.
- Quarterly Other Non-Current Liabilities fell 88.84% year-over-year to $51.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $51.0 (down 88.84% YoY) and the FY2024 annual result came in at $381.0, down 98.93% from the prior year.
- Other Non-Current Liabilities was $51.0 for Q3 2025 at Azitra, down from $184.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $158994.0 in Q2 2023 and bottomed at $51.0 in Q3 2025.
- A 4-year average of $30654.4 and a median of $2926.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities plunged 49.56% — and 2024, when it tumbled 99.25%.
- Azitra's Other Non-Current Liabilities stood at $70283.0 in 2022, then plunged by 49.56% to $35453.0 in 2023, then plunged by 98.93% to $381.0 in 2024, then tumbled by 86.61% to $51.0 in 2025.
- Business Quant data shows AZTR's Other Non-Current Liabilities at $51.0 in Q3 2025, $184.0 in Q2 2025, and $238.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.00 |
| Jun 30, 2025 | 184.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 381.00 |
| Sep 30, 2024 | 457.00 |
| Jun 30, 2024 | 2,926.00 |
| Mar 31, 2024 | 7,298.00 |
| Dec 31, 2023 | 35,453.00 |
| Sep 30, 2023 | 60,933.00 |
| Jun 30, 2023 | 158,994.00 |
| Dec 31, 2022 | 70,283.00 |